Improvement of core-fucosylated glycoproteome coverage via alternating HCD and ETD fragmentation.
Core-fucosylation (CF) plays important roles in regulating biological processes in eukaryotes. Alterations of CF-glycosites or CF-glycans in bodily fluids correlate with cancer development. Therefore, global research of protein core-fucosylation with an emphasis on proteomics can explain pathogenic and metastasis mechanisms and aid in the discovery of new potential biomarkers for early clinical diagnosis. In this study, a precise and high throughput method was established to identify CF-glycosites from human plasma. We found that alternating HCD and ETD fragmentation (AHEF) can provide a complementary method to discover CF-glycosites. A total of 407 CF-glycosites among 267 CF-glycoproteins were identified in a mixed sample made from six normal human plasma samples. Among the 407 CF-glycosites, 10 are without the N-X-S/T/C consensus motif, representing 2.5% of the total number identified. All identified CF-glycopeptide results from HCD and ETD fragmentation were filtered with neutral loss peaks and characteristic ions of GlcNAc from HCD spectra, which assured the credibility of the results. This study provides an effective method for CF-glycosites identification and a valuable biomarker reference for clinical research.



CF-glycosytion plays an important role in regulating biological processes in eukaryotes. Alterations of the glycosites and attached CF-glycans are frequently observed in various types of cancers. Thus, it is crucial to develop a strategy for mapping human CF-glycosylation. Here, we developed a complementary method via alternating HCD and ETD fragmentation (AHEF) to analyze CF-glycoproteins. This strategy reveals an excellent complementarity of HCD and ETD in the analysis of CF-glycoproteins, and provides a valuable biomarker reference for clinical research.
Department of Chemistry, Center for Diagnostics & Therapeutics, Georgia State University, Atlanta, GA 30303, United States. Electronic address: cma@gsu.edu.
Cheng
C
Ma
Department of Chemistry, Center for Diagnostics & Therapeutics, Georgia State University, Atlanta, GA 30303, United States.
Jingyao
J
Qu
Department of Chemistry, Center for Diagnostics & Therapeutics, Georgia State University, Atlanta, GA 30303, United States.
Xu
X
Li
National Institute of Biological Sciences, Beijing 102206, People's Republic of China.
Xinyuan
X
Zhao
Department of Chemistry, Center for Diagnostics & Therapeutics, Georgia State University, Atlanta, GA 30303, United States.
Lei
L
Li
Department of Chemistry, Center for Diagnostics & Therapeutics, Georgia State University, Atlanta, GA 30303, United States.
Cong
C
Xiao
Department of Chemistry, Center for Diagnostics & Therapeutics, Georgia State University, Atlanta, GA 30303, United States.
Garrett
G
Edmunds
Department of Chemistry, Center for Diagnostics & Therapeutics, Georgia State University, Atlanta, GA 30303, United States.
Ebtesam
E
Gashash
Department of Chemistry, Center for Diagnostics & Therapeutics, Georgia State University, Atlanta, GA 30303, United States.
Jing
J
Song
Department of Chemistry, Center for Diagnostics & Therapeutics, Georgia State University, Atlanta, GA 30303, United States. Electronic address: pwang11@gsu.edu.
Peng George
PG
Wang
D020816:Amino Acid Motifs; D001798:Blood Proteins / Q000032:analysis* / Q000737:chemistry; D016384:Consensus Sequence; D005643:Fucose / Q000378:metabolism*; D006020:Glycopeptides / Q000032:analysis*; D006031:Glycosylation; D006801:Humans; D010446:Peptide Fragments / Q000032:analysis; D040901:Proteomics / Q000379:methods*
D001798:Blood Proteins; D006020:Glycopeptides; D010446:Peptide Fragments; D005643:Fucose
Core-fucosylation; ETD; HCD; Human plasma